glp-1 and glp-2 Glucagon Like Peptide 2 Receptor - an overview What is the Difference Between
Description
Coverage can vary widely depending on an individuals employer, plan type, and state regulations
Larger randomized placebo-controlled trials including a variety of patient populations (ie, those with metabolic syndrome versus those without) are needed to confirm efficacy of GLP-1RAs according to patient type
FDA labels specifically warn about this risk
Comput Intell Neurosci
